
Ask a doctor about a prescription for LORAZEPAM PENSA 5 mg TABLETS
Package Leaflet: Information for the Patient
Lorazepam Pensa 5 mg Tablets EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Lorazepam is a tranquilizer-anxiolytic (prevents nervousness and anxiety) that acts without influencing the normal activities of the individual. It complements antidepressant therapy and can be combined with antidepressant medications and other psychotropic drugs.
Lorazepam is used in the following cases:
Do not take Lorazepam Pensa:
Consult your doctor or pharmacist before starting to take Lorazepam Pensa.
Children
Benzodiazepines are not recommended in children under 6 years of age unless strictly necessary. The duration of treatment should be as short as possible.
Tolerance
After continued use for several weeks, a certain degree of loss of efficacy with respect to hypnotic effects may be detected.
Dependence
Continued use of benzodiazepines for several weeks may lead to some loss of efficacy with respect to hypnotic effects. It can also lead to dependence. This usually occurs mainly after uninterrupted use of the medication for a long time. To prevent this risk as much as possible, the following instructions should be taken into account:
Amnesia
Benzodiazepines can induce amnesia. This fact occurs more frequently after several hours after administration of the medication, so to reduce the associated risk, patients should ensure that they sleep uninterruptedly for 7-8 hours after taking the tablet.
Psychiatric and Paradoxical Reactions
In treatment with benzodiazepines, pre-existing depressions or worsening of the depressive state may reappear. Additionally, suicidal tendencies in depressive patients may be masked, which should be monitored in these patients.
Elderly and Debilitated Patients
Elderly and debilitated patients should receive a lower dose since they are more susceptible to the effects of the medication.
Use in Patients with Respiratory Failure
It is recommended to use lower doses in patients with chronic respiratory failure due to the associated risk of respiratory depression, such as in patients with chronic obstructive pulmonary disease (COPD) or sleep apnea syndrome.
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
It should be taken into account that all benzodiazepines produce depressant effects on the central nervous system (CNS), if administered together with barbiturates or alcohol. When lorazepam is taken with other medications that act on the CNS, the combination can make you feel more drowsy than necessary. These medications include:
Similarly, the concomitant administration of lorazepam with other medications can alter the effect of lorazepam, prolonging or decreasing its activity. These medications include:
Taking Lorazepam Pensa with Food, Drinks, and Alcohol
Lorazepam can be taken with and without food.
Alcohol increases the sedative effect of this medication, so it is recommended to avoid consuming alcoholic beverages.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy:
Inform your doctor if you are or plan to become pregnant.
The use of benzodiazepines appears to be related to a possible increased risk of congenital malformations in the first trimester of pregnancy. The passage of benzodiazepines and their derivatives through the placenta has been detected.
If, on medical advice, the product is administered during a late stage of pregnancy or at high doses during labor, it is foreseeable that effects on the newborn may appear, such as hypoactivity, hypothermia (decrease in body temperature), hypotonia (decrease in muscle tone), apnea (period of lack of breathing), moderate respiratory depression, feeding problems, and metabolic response imbalance to stress from cold.
Children born to mothers who take benzodiazepines chronically during several weeks of pregnancy or during the last period of pregnancy may develop physical dependence and trigger withdrawal syndrome in the postnatal period.
Breastfeeding:
This medication should not be used during breastfeeding, as benzodiazepines are excreted in breast milk. Cases of sedation and inability to breastfeed have been detected in newborns whose mothers were under treatment with benzodiazepines. These newborns should be monitored to detect any of the mentioned pharmacological effects (sedation and irritability).
Lorazepam can alter your ability to drive or operate machinery, as it can cause drowsiness, decrease your attention, or decrease your reaction capacity. The appearance of these effects is more likely at the start of treatment or when the dose is increased. Do not drive or use machines if you experience any of these effects.
Lorazepam Pensa contains Lactose and Sodium
This medication contains lactose. If your doctor has indicated that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 23 mg of sodium (1 mmol) per tablet; this is, essentially “sodium-free”.
Follow the administration instructions of this medication exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Your doctor will indicate the duration of your treatment. Do not stop treatment before it is finished, as it may not have the desired effect.
The recommended dose in adults is half a tablet or 1 tablet (0.5 or 1 mg of lorazepam) 2 to 3 times a day, which means a maximum of 3 mg of lorazepam, administered orally, with or without food. This dose may be increased or decreased according to the needs or age of the patient, and at the discretion of the doctor.
If you take more Lorazepam Pensa than you should
Although intoxication with benzodiazepines is very rare, if you have taken more lorazepam than you should, consult your doctor or pharmacist immediately, or call the Toxicological Information Service. Phone: 91 562 04 20.
The most frequent symptoms of intoxication are excessive drowsiness, confusion, or coma.
Treatment of overdose includes inducing vomiting or gastric lavage, general maintenance measures, adequate breathing, monitoring of vital signs, and proper control of the patient. Flumazenil may be used as an antidote. In patients who take benzodiazepines chronically, special care should be taken when administering flumazenil, as this combination of medications can increase the risk of seizures.
If you forget to take Lorazepam Pensa
Do not take a double dose to make up for forgotten doses.
If you stop taking Lorazepam Pensa
When stopping administration, the symptoms that led you to take the medication may reappear, as well as restlessness, muscle pain, anxiety, tension, unease, confusion, and irritability, insomnia, lack of concentration, headache, sweating, depression, rebound phenomena, derealization (unreal or unknown perception of the immediate environment), dizziness, depersonalization (disconnection from reality), involuntary movements, nausea, vomiting, diarrhea, loss of appetite, tremors, abdominal cramps, palpitations, tachycardia, panic attacks, vertigo, hyperreflexia (excessive stimulation), short-term memory loss, and hyperthermia (increase in body temperature), so your doctor will indicate precisely how to gradually decrease the dose.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not all people experience them.
The following side effects are described according to their frequency of occurrence in treated patients:
Very common: at least 1 in 10 patients.
Common: at least 1 in 100 patients.
Uncommon: at least 1 in 1,000 patients.
Rare: at least 1 in 10,000 patients.
Very rare: less than 1 in 10,000 patients.
Frequency not known: cannot be estimated from available data.
Very common: Feeling of suffocation.
Common: Asthenia (fatigue, tiredness).
Frequency not known: Hypothermia (decrease in body temperature)
Frequency not known: Hypotension (decrease in blood pressure).
Uncommon: Nausea
Frequency not known: Constipation.
Hepatobiliary Disorders
Frequency not known: Jaundice (yellowing of the whites of the eyes and skin).
Blood and Lymphatic System Disorders
Frequency not known: Thrombocytopenia (decrease in platelets), agranulocytosis (decrease in neutrophils, a type of white blood cell), and pancytopenia (significant decrease in all blood cells).
Immune System Disorders
Frequency not known: Hypersensitivity and anaphylactic/anaphylactoid reactions (allergic).
Endocrine Disorders
Frequency not known: Syndrome of inappropriate antidiuretic hormone secretion.
Metabolism and Nutrition Disorders
Frequency not known: Hyponatremia (lack of sodium).
Psychiatric Disorders
Common: Confusion, depression, unmasking of depression.
Uncommon: Change in libido (sexual desire), decreased orgasms.
Frequency not known: Disinhibition, euphoria, suicidal ideas and attempts, paradoxical reactions such as anxiety, agitation, excitement, hostility, aggression, fury, sleep disturbances/insomnia, sexual desire, and hallucinations.
Nervous System Disorders
Very common: Sedation, somnolence.
Common: Ataxia (motor coordination and speech problems), dizziness.
Frequency not known: Extrapyramidal symptoms: tremors, dysarthria (difficulty articulating words), headache, seizures, amnesia, coma, attention/concentration disorders, balance disorders.
Eye Disorders
Frequency not known: Visual problems (double vision and blurred vision).
Ear and Labyrinth Disorders
Frequency not known: Vertigo.
Reproductive System and Breast Disorders
Uncommon: Impotence.
Respiratory, Thoracic, and Mediastinal Disorders
Frequency not known: Respiratory failure, apnea, worsening of sleep apnea. Worsening of chronic obstructive pulmonary disease (COPD).
Skin and Subcutaneous Tissue Disorders
Frequency not known: Angioedema (swelling under the skin of the tongue, glottis, or larynx that can produce a blockage of the airways that can be fatal), allergic skin reactions, alopecia (hair loss).
Musculoskeletal and Connective Tissue Disorders
Common: Muscle weakness.
Investigations
Frequency not known: Increased bilirubin, increased transaminases, and increased alkaline phosphatase (liver enzyme).
As indicated above, withdrawal of the product may cause the reappearance of certain symptoms as a consequence of dependence development.
If you consider that any of the side effects you are experiencing is serious or if you notice any side effect not mentioned in this package leaflet, inform your doctor or pharmacist.
Reporting of Side Effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Do not store above 30°C.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after "CAD". The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of Lorazepam pensa
Appearance of the Product and Container Content:
Lorazepam pensa is presented in the form of white, cylindrical, biconvex, scored tablets with the logo L5 on one of the faces. They can be divided into equal halves.
Each container contains 20 tablets in PVC-PVDC/aluminum blisters.
Marketing Authorization Holder
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Manufacturer
Laboratorios Cinfa, S.A.
C/ Olaz-Chipi, 10 - Polígono Industrial Areta.
31620 Huarte - Pamplona (Navarra)
Spain
Date of the Last Revision of this Leaflet:December 2020
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of LORAZEPAM PENSA 5 mg TABLETS in November, 2025 is around 1.12 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LORAZEPAM PENSA 5 mg TABLETS – subject to medical assessment and local rules.